Silicon Biosystems has developed a set of proprietary solutions called lab-on-a-chip technologies, targeted at miniaturized cell-biology testing. Silicon Biosystems exploits the microelectronics potential in order to produce miniaturized cellular biology laboratories. The approach patented by Silicon Biosystems has given rise to an unprecedented technology platform able to perform complex protocols, since it offers the unique possibility of controlling individual cells and micro-particles inside a micro-chamber. Silicon Biosystems technology individually manages more than 100,000 cells on a single microelectronic chip, using software control and incorporating sensors to detect the results of complex procedures. The company has a reputation for being one of the most innovative start-ups in the field of ?ab-on-a-chip?based on active substrates, as testified by a number of awards and recognitions. Silicon Biosystems is also an industrial member of the nano2Life EC Network of Excellence on nanobiotechnologies.
The only automated instrument that can identify, quantify, and recover individual rare cells. The DEPArray™ System enables isolation of individual, intact cells, allowing researchers to study the biological significance of rare cells in disease development, progression, and therapeutic response.The DEPArray™ System can analyze samples containing from one to tens of thousands of cells and is compatible with a wide variety of r…
